Samjin Pharm
Korea - SeoulBiotechnology
Focus: Samjin Pharm is a Korean biotechnology company focused on small molecule development in neurology and cardiovascular disease. Scale and market position data are not publicly available.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Samjin Pharm
AI assessmentNot HiringNo open roles listed right now. Follow Samjin Pharm to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
General principles of care and judgement of researcher
Acute Ischemic StrokeClinical Trials (1)
NCT04072705Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
N/AHelp build intelligence for Samjin Pharm
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.